Skip to main content

Table 3 Determination of IND and GLY in commercial inhaler capsules

From: Rapid simultaneous determination of indacaterol maleate and glycopyrronium bromide in inhaler capsules using a validated stability-indicating monolithic LC method

Formulation Labelled amount Mean found Recoverya (%)
IND GLY IND GLY IND GLY
Ultibro® Breezhaler® 110 50 110.73 50.58 100.67 ± 0.35 101.16 ± 0.47
Onbrez Breezhaler® 150 150.54 100.36 ± 0.26
Seebri® Breezhaler® 50 50.25 100.49 ± 0.56
  1. aEach result is the average of three separate determinations